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Abstract
Background: Ultrasonography of temporal arteries is not commonly used in the approach of patients with
suspected giant cell arteritis (GCA) in clinical practice. A meta-analysis of primary studies available through April
2004 concluded that ultrasonography could indeed be helpful in diagnosing GCA. We specifically re-examined the
diagnostic value of the ultrasonography-derived halo sign, a dark hypoechoic circumferential thickening around the
artery lumen, indicating vasculitic wall edema, in GCA.
Methods: Original, prospective studies in patients with suspected GCA that examined ultrasonography findings of
temporal arteries using the ACR 1990 classification criteria for GCA as reference standard, published through 2009,
were identified. Only eight studies involving 575 patients, 204 of whom received the final diagnosis of GCA,
fulfilled technical quality criteria for ultrasound. Weighted sensitivity and specificity estimates of the halo sign were
assessed, their possible heterogeneity was investigated and pooled diagnostic odds ratio was determined.
Results: Unilateral halo sign achieved an overall sensitivity of 68% (95% CI, 0.61-0.74) and specificity of 91% (95%
CI, 0.88-0.94) for GCA. The values of inconsistency coefficient (I
2) of both sensitivity and specificity of the halo sign,
showed significant heterogeneity concerning the results between studies. Pooled diagnostic odds ratio, expressing
how much greater the odds of having GCA are for patients with halo sign than for those without, was 34 (95% CI,
8.21-138.23). Diagnostic odds ratio was further increased to 65 (95% CI, 17.86-236.82) when bilateral halo signs
were present (sensitivity/specificity of 43% and 100%, respectively). In both cases, it was found that DOR was
constant across studies.
Conclusion: Temporal artery edema demonstrated as halo sign should be always looked for in ultrasonography
when GCA is suspected. Providing that currently accepted technical quality criteria are fulfilled, halo sign’s
sensitivity and specificity are comparable to those of autoantibodies used as diagnostic tests in rheumatology.
Validation of revised GCA classification criteria which will include the halo sign may be warranted.
Background
According to the American College of Rheumatology
(ACR) 1990 criteria for the classification of vasculitis,
diagnosis of temporal or giant-cell arteritis (GCA), the
most common form of systemic vasculitis in adults, is
based on clinical grounds and the result of a temporal
artery biopsy. The presence of three or more of the fol-
lowing five criteria, (1) age of 50 years and older, (2)
new onset of localized headache, (3) temporal artery
tenderness on palpation or decreased pulsation, (4) ery-
throcyte sedimentation rate of 50 mm/h and higher, (5)
abnormal temporal artery biopsy, yields a sensitivity of
93.5% and a specificity of 91.2% for the diagnosis of
GCA when compared to other vasculitides [1,2].
Because of the possible development of severe ischemia,
i.e. visual impairment with loss of vision occurring in
almost 15% of patients, early diagnosis of GCA and
prompt initiation of treatment is mandatory. Certainty
about the correct diagnosis is imperative in view of the
potentially important adverse affects of the required
long-term corticosteroid treatment. Since the most spe-
cific findings in patients’ history, physical examination
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50%, a temporal artery biopsy has traditionally been
recommended [2].
In 1997, Schmidt and colleagues were the first to exam-
ine the use of ultrasonography of the temporal arteries in
the diagnosis of GCA [3]. When applied to inflamed tem-
poral arteries, ultrasonography may show, a) edema,
referred to as halo sign, indicated by a dark hypoechoic
circumferential wall thickening around the artery lumen
which disappears after corticosteroid treatment within 2-
3 weeks, b) stenoses, expressed by segmental increases of
blood flow velocity, and, c) occlusions, expressed by the
absence of flow in the temporal artery (on color or power
doppler ultrasonography). During the last decade ultraso-
nography has attracted considerable interest as a non-
invasive diagnostic tool for patients suspected of having
GCA. A meta-analysis of primary studies available
through April 2004 [4] concluded that halo sign, stenoses
and occlusions demonstrated by ultrasonography could
be indeed helpful in diagnosing GCA. On the other hand,
in an elegant study published in 2002, Salvarani et al sta-
ted that ultrasonography is not better than a careful phy-
sical examination for the detection of a biopsy positive
GCA [5].
In a more recent controlled study performed in our
center [6], it was found that blood flow alterations (ste-
noses and/or occlusions) demonstrated in temporal
arteries with doppler ultrasonography are neither speci-
f i cn o rs e n s i t i v ef o rG C A ,s i n c et h e s ef i n d i n g sw e r e
equally common among elderly individuals or patients
with macrovascular disease associated with diabetes mel-
litus or stroke, due to the temporal artery atherosclero-
tic changes. The presence of unilateral halo alone
yielded 82% sensitivity and 91% specificity for GCA in
our study, while the specificity reached 100% when
halos were found bilaterally. At follow-up ultrasonogra-
phy examinations performed at 2 and 4 weeks following
initiation of corticosteroid treatment for GCA, halos dis-
appeared in all patients [6]. To further explore the uti-
lity of ultrasonography in patients with clinically
suspected GCA, we examined the specific value of the
halo sign for GCA diagnosis in a meta-analysis which
includes only prospective studies that meet technical
quality criteria for ultrasound [7,8].
Methods
We conducted an extensive Medline/PubMed, EMBASE
and Cochrane databases search for original primary stu-
dies published in any language through December 2009
that examined the sensitivity and specificity of the halo
sign demonstrated by temporal artery ultrasonograply
for GCA diagnosis versus the ACR 1990 criteria for the
classification of vasculitis, used as a reference standard
[1]. The search strategy was based on combination of
index terms: giant cell arteritis, temporal arteritis, vascu-
litis, ultrasonography, duplex, Doppler, ultrasound, diag-
nosis. Primary studies which did not examine the
diagnostic value of the halo sign independently of con-
comitant blood flow abnormalities were not included in
this meta-analysis. We analysed only prospective studies
which enrolled patients with clinically suspected GCA,
including patients who had initially received the diagno-
sis of polymyalgia rheumatica. All studies used color
doppler or duplex ultrasonography with appropriate
color intensity and doppler settings [7]. The temporal
arteries were examined in both longitudinal and trans-
verse plane. Because there is substantial variability in
equipment from machine to machine, from manufac-
turer to manufacturer, and between older and newer
ultrasound equipment, only studies that used industry-
wide standards for Doppler measurement were included
[7,8], in contrast to the previous meta-analysis in which
studies were eligible regardless of the ultrasound quality
method used [4].
Statistical analysis
Sensitivity and specificity estimates of the halo sign
together with their 95% confidence intervals were calcu-
lated for each study and for the total sample size of stu-
dies. Two meta-analytic methods of weighted
independent estimation of overall sensitivity and specifi-
city were applied to overcome biased estimation of such
calculations; namely, the fixed effect model of Mantel-
Haenzel weights each study by the inverse of its variance
[9], whereas the random effects model by DerSimonian-
Laird also incorporates between study variation and it
usually yields wider confidence intervals [10], thus is
preferable in a proven heterogeneity between studies.
The heterogeneity of sensitivity and specificity between
studies was evaluated using Cochran’sQa n dc h i -
square-test, followed by the calculation of inconsistency
(I
2). The I
2 statistic is calculated from Q and can be
interpreted as the percentage variability in study results
attributable to between-study differences rather than
chance [11]. The degree of variability among results of
different studies was also evaluated graphically by plot-
ting the sensitivity and specificity from each study on a
forest plot.
Because the sensitivity and specificity are by their nat-
ure dependent on each other, a more appropriate analy-
sis, which takes into account their independence, such
as the summary receiver-operating characteristic (sROC)
curve analysis was also applied. The sROC curve is well
established as a method of summarizing the perfor-
mance of a diagnostic test [12]. The area under the
ROC curve (AUC) and the index Q* are useful summary
measures: AUC is maximized when the study odds ratio
are homogeneous (equals with 1 for a perfect test),
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o v e r ,t h ed i a g n o s t i co d d sr a t i o( D O R ) ,a na d d i t i o n a l
measure of the test accuracy, useful in meta-analysis,
was determined [15]. The DOR expresses how much
g r e a t e rt h eo d d so fh a v i n gt h ed i s e a s ea r ef o ras u b j e c t
with a positive test result than for a subject with a nega-
tive test result.
Since an important extra source of variation in meta-
analysis of diagnostic accuracy relates to the fact that
different studies may have used, explicitly or implicitly,
different thresholds to define positive and negative test
results, Spearman correlation coefficient between the
sensitivity and specificity was used (if the threshold
effect exists an inverse correlation appears). A visual cue
to the possible existence of this source of variation can
be given by the plot the sensitivity and specificity on a
ROC plane. If such a threshold effect exists, the points
will show a curvilinear pattern. This hypothesis can be
tested using Moses’ regression model, both with
unweighted and weighted, with inverse variance. If the
slope (b) of the regression equation is not significantly
different from zero, then we can assume that DOR is
constant and that there is no heterogeneity between the
studies.
Results
Of a total of 16 primary studies that examined the diag-
nostic value of the halo sign demonstrated by temporal
artery ultrasonograply versus the ACR 1990 criteria for
the classification of vasculitis, used as a reference stan-
dard [3,5,6,16-28], only 9 studies met our inclusion/
exclusion criteria [3,5,6,17-19,21,24,27]. To avoid dupli-
cate reports on the same patients, one study [3] was
excluded. Collectively, the 8 remaining studies, from 7
centers, involved 575 different patients (each of them
reported once). These patients had suspected GCA and
underwent temporal artery ultrasonography before
biopsy. Of them, 204 received a final diagnosis of GCA
diagnosis on the basis of 3 or more of the ACR classifi-
cation criteria [1]
As shown in Figure 1, the presence of unilateral halo
sign achieved an overall sensitivity of 68% and an overall
specificity of 91% compared with final diagnosis. The
area under the sROC curve (AUC) was 0.87 (SE = 0.09)
with a Q* point value, denoting the diagnostic at which
the correct diagnosis is constant for all subjects, of 0.80
(95% CI 0.62-0.97) (SE = 0.0883).
Notably, there was significant heterogeneity between
the studies in terms of sensitivity (chi-square test and
inconsistency were 24.12, p < 0.001 and 71%, respec-
tively), as well as in terms of specificity (chi-square test
and inconsistency were 47.37, p < 0.001 and 85.2%,
respectively). As also shown by the sROC curves
depicted in Figure 2, there was a significant variation
concerning the diagnostic thresholds between studies to
define positive and negative results. The Spearman cor-
relation coefficient of sensitivity with specificity was
0.238 (p = 0.570). Likewise, both unweighted and
weighted Moses’ models showed that the slope (b) of
the regression equation did not differ from zero, imply-
ing a constant DOR and no heterogeneity between
studies.
As shown in Figure 3, the pooled DOR of the unilat-
eral halo sign for GCA was equal to 33.69 (95% CI =
8.21-138.23). The discrimination power (ln(OR)) was
3.52 (95% CI 2.11-4.93).
Finally, 4 studies, including a total of 380 patients pro-
vided data concerning the presence of bilateral halo in
CDS [6,17,21,24]. Indeed, 62 of 63 patients with bilateral
halo were diagnosed with GCA resulting in a specificity
of 100%, whereas sensitivity was 43%. As shown in Fig-
ure 3, pooled DOR of bilateral halo reached 65.03 (95%
CI = 17.86-236.82). The discrimination power (ln(OR))
was 4.17 (96% CI 2.88-5.47).
Discussion and Conclusions
Our meta-analysis revealed a sensitivity of 68% and a
specificity of 91% for the unilateral halo sign, as well as
43% and 100%, respectively, for the bilateral halo sign in
temporal artery ultrasonography for GCA diagnosis,
when the 1990 ACR criteria are used as the reference
standard. Possible limitations of these criteria have been
discussed in the literature [29], but revision(s) are not
available to date. In the first meta-analysis by Karassa et
al, assessing the test-performance of ultrasonography for
GCA in studies published up to April 2004, the sensitiv-
ity and specificity of the halo sign versus ACR criteria
(without referring to unilateral or bilateral presence)
were reported to be 55% and 94%, respectively [4]. The
considerably higher sensitivity of the unilateral halo
reported herein, in addition to the inclusion of 2 recent
studies [6,27], is most probably due to significant quality
differences among studies collectively analysed in the
previous meta-analysis without applying established
technical quality criteria for ultrasound. We avoided
presenting an additional analysis of how the presence of
blood flow abnormalities (stenoses/occlusions) would
further increase the sensitivity of ultrasonography
because very limited information on the coexistence of
halo sign with such abnormalities, which are common
findings in elderly patients without GCA [6], was pro-
vided in relevant studies.
We restricted our analysis to studies using the ACR
criteria as reference standard. Those studies focusing
only on comparison between ultrasonography and tem-
poral artery biopsy findings [30-38] were not analysed.
In our opinion, such a comparison could be misleading
given the fact that biopsy has a high probability of false
Arida et al. BMC Musculoskeletal Disorders 2010, 11:44
http://www.biomedcentral.com/1471-2474/11/44
Page 3 of 8negative results because of the segmental nature of the
disease, and thus cannot exclude the diagnosis of vascu-
litis when negative [39-41]. For example, in a recent
study, 19% of patients with suspected GCA and a nega-
tive temporal artery biopsy were eventually diagnosed as
GCA. Diagnosis was established on the basis of at least
3 of the remaining ACR classification criteria, improve-
ment of symptoms within 3 days of corticosteroid ther-
apy and the absence of other condition relevant to the
patients’ symptoms during a 6-month follow-up [42]. A
similar percentage of 19% of patients with GCA had
negative biopsy results in a cohort of 271 patients from
another center [43]. Moreover, as a recent study sug-
gests, up to 13% of patients with GCA could have been
misdiagnosed as biopsy-negative had a biopsy been done
only unilaterally [44], which is the case in the vast
majority of patients included in all relevant studies.
Finally, in 8 of 9 studies analysed herein, the presence of
Figure 1 Forest plot of the sensitivity and specificity of the temporal artery ultrasonography- derived halo sign compared to final
diagnosis of giant-cell arteritis in patients with suspected disease.
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poral artery biopsy, clearly leading to an underestima-
tion of the true diagnostic performance of the halo sign.
A sensitivity of 68% and a specificity of 91% for the
unilateral halo sign in temporal artery ultrasonography
for GCA diagnosis, when the ACR criteria are used as
the reference standard, are comparable to sensitivity and
specificity estimates of other diagnostic tests that are
widely used in rheumatology. For example, in a meta-
analysis on the diagnostic value of autoantibody mea-
surements in rheumatoid arthritis, the sensitivity and
specificity of rheumatoid factor were 69% and 85%,
respectively, whereas of anti-cyclic citrullinated peptide
were 67% and 95% [45]. Moreover, anti-dsDNA antibo-
dies measured by commercially available ELISA have
sensitivities and specificities of 61% and 95%, respec-
tively, for systemic lupus erythematosus [46]. Both rheu-
matoid factor and anti-dsDNA antibodies are included
in the sets of ACR classification criteria for the respec-
tive diseases.
Interestingly, the values of inconsistency coefficient
(I
2) of both sensitivity and specificity of the halo sign,
showed significant heterogeneity concerning the results
between studies, probably caused by a threshold effect.
It is difficult to assume that this threshold effect is attri-
butable only to ultrasonography findings per se.O t h e r
contributing factors may be differences in clinical diag-
nostic skills or biopsy method, and/or interpretation of
histology results across studies. In addition, referral of
patients for ultrasonography by physicians non-specia-
lised to connective tissue diseases, i.e. internists, general
practitioners, ophthalmologists, or neurologists may lead
to a low pretest probability for positive GCA in some
studies. Such factors may clearly result to variability
between studies concerning the diagnostic thresholds.
Because of the trade-off nature of sensitivity and spe-
cificity, meta-analysis of diagnostic tests using these
conventional expressions offers statistical challenges.
Simple pooling of sensitivity and specificity may be not
the most appropriate approach, as it ignores threshold
differences. In addition, heterogeneity may lead to an
underestimation of a test’s performance. More recent
evidence suggests that a more important index to define
the accuracy of a given test result as a diagnostic tool is
the pooled DOR [15]. The DOR offers considerable
advantages in meta-analysis of diagnostic studies as it
combines results from different studies into summary
estimates with increased precision. In the present meta-
analysis the pooled DOR of the unilateral halo sign was
as high as 34. When bilateral halo signs were present,
pooled DOR was higher than 65, indicating a consider-
able diagnostic accuracy of ultrasonography for GCA.
Figure 2 Summary receiver-operating characteristic (sROC) curves of the temporal artery ultrasonography- derived halo sign
compared to final diagnosis of giant-cell arteritis in patients with suspected disease.
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constant across studies.
The results presented herein confirm that the halo
sign in ultrasonography is useful in diagnosing GCA. A
previously proposed algorithm [4] suggests that after a
careful clinical examination and assessment of relevant
laboratory data temporal artery ultrasonography exami-
nation should precede the biopsy in patients with sus-
pected GCA, whereas among the various abnormalities
which can be found in ultrasonography, only the halo
sign should be considered. In case of bilateral halo
signs, treatment could be initiated without proceeding
with biopsy. If unilateral halos are present, a decision of
directional biopsy is justified [4]. The results of the pre-
sent meta-analysis further substantiate this algorithm.
Moreover, in a recent study involving 182 patients from
a single center, albeit not using the ACR criteria as the
reference standard, it was found that GCA can be accu-
rately diagnosed or excluded by ultrasonography, with-
out biopsy, in two thirds of patients [28].
Comparing to temporal artery biopsy, ultrasonography
is very well tolerated, more accessible, less costly and a
more rapid and easier to perform procedure, with high
reproducibility. An additional important advantage of
ultrasonography is that full-length examination of the
superficial temporal and other cranial arteries is allowed.
Experts in the field suggest that certain parameters
should be fulfilled for a correct US examination of the
temporal arteries; namely, high-quality color Doppler
US equipment with a linear probe that exhibits a fre-
quency of more than 8 MHz, adequate experience with
vascular US, knowledge of the US image of a normal
temporal artery, and standardized US machine adjust-
ments [47]. The color signal should cover the artery
lumen exactly, not extend over parts of the lumen or
cover only the center of the lumen. Along these lines, a
sonographer should have investigated at least 50 persons
without temporal arteritis to acquire relevant experience
on the appearance of a normal temporal artery before
assessing patients with suspected GCA [47].
Figure 3 Diagnostic Odds Ratios of the temporal artery ultrasonography- derived unilateral (upper panel) and bilateral (lower panel)
halo sign compared to final diagnosis of giant-cell arteritis in patients with suspected disease.
Arida et al. BMC Musculoskeletal Disorders 2010, 11:44
http://www.biomedcentral.com/1471-2474/11/44
Page 6 of 8The present meta-analysis, however, is by design
unable to show a direct superiority of ultrasonography
to microscopic examination of temporal artery biopsy,
which might have some additional prognostic impor-
tance. As recently demonstrated in a study of 391 biopsy
specimens from patients with GCA, the presence of
giant cells was strongly associated with permanent visual
loss, the most feared disease complication [48] On the
other hand, studies have shown that ultrasound of the
axillary arteries could increase the diagnostic yield for
large vessel GCA, as characteristic findings, such as
hypoechoic wall thickening and/or stenosis, are present
in the vast majority of patients [49]. Finally, with recent
and ongoing progress in probe technology, with gradu-
ally higher frequencies and matrix technology, sensitiv-
ities of the halo sign higher than 68% might be expected
[50].
To conclude, temporal artery edema demonstrated as
halo sign in ultrasonography, providing that technical
quality criteria are fulfilled [51], should be always looked
for in patients with suspected GCA. The diagnostic
accuracy of the halo sign for GCA seems to be compar-
able to anti-cyclic citrullinated peptide antibody and
rheumatoid factor for rheumatoid arthritis, or to anti-
dsDNA antibody for systemic lupus erythematosus. The
findings of this meta-analysis suggest that validation of a
revised set of classification criteria for GCA which will
include the halo sign is warranted.
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